Christos Papaneophytou
Overview
Explore the profile of Christos Papaneophytou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andreou E, Georgaki E, Vlahoyiannis A, Philippou C, Ntorzi N, Christoforou C, et al.
Nutrients
. 2025 Jan;
17(2.
PMID: 39861344
During the COVID-19 pandemic, people were asked to stay at home. Places where people interacted such as schools, universities, and cafes were closed, and all gatherings were forbidden. Only stores...
2.
Andreou E, Mouski C, Georgaki E, Andreou N, Christoforou C, Abboud M, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39770928
Background: Obesity and related health challenges remain significant concerns in Cyprus and Greece. Mindful eating (ME) has emerged as a behavioral approach to address these issues, yet its relationship with...
3.
Papaneophytou C
Front Biosci (Landmark Ed)
. 2024 Dec;
29(12):402.
PMID: 39735988
The Warburg effect, also known as 'aerobic' glycolysis, describes the preference of cancer cells to favor glycolysis over oxidative phosphorylation for energy (adenosine triphosphate-ATP) production, despite having high amounts of...
4.
Papaneophytou C
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125676
Respiratory viral infections (VRTIs) rank among the leading causes of global morbidity and mortality, affecting millions of individuals each year across all age groups. These infections are caused by various...
5.
Vlasiou M, Zacharia L, Douni E, Papaneophytou C
Front Pharmacol
. 2024 Jul;
15:1455646.
PMID: 39076589
No abstract available.
6.
Sideratou C, Papaneophytou C
Infect Dis Rep
. 2024 Jul;
16(4):561-571.
PMID: 39051242
Angiotensin-converting enzyme 2 (ACE2), a key regulator in vasoregulation and the renin-angiotensin system, is hypothesized to be downregulated in patients with COVID-19, leading to a cascade of cardiovascular complications. This...
7.
Panayi T, Diavoli S, Nicolaidou V, Papaneophytou C, Petrou C, Sarigiannis Y
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786150
Scorpion venom peptides are generally classified into two main groups: the disulfide bridged peptides (DBPs), which usually target membrane-associated ion channels, and the non-disulfide bridged peptides (NDBPs), a smaller group...
8.
Tsilimingkra N, Papaneophytou C
Curr Top Med Chem
. 2024 May;
24(15):1343-1358.
PMID: 38698747
Background: Human rhinovirus 3C protease (HRV-3C) plays a crucial role in viral proliferation, establishing it as a prime target for antiviral therapy. However, research on identifying HRV-3C inhibitors is still...
9.
Felekkis K, Papaneophytou C
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542382
The potential of liquid biopsy for the prognosis and diagnosis of diseases is unquestionable. Within the evolving landscape of disease diagnostics and personalized medicine, circulating microRNAs (c-miRNAs) stand out among...
10.
Sideratou C, Papaneophytou C
Infect Dis Rep
. 2023 Dec;
15(6):806-830.
PMID: 38131885
The coronavirus disease 2019 (COVID-19), instigated by the zoonotic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), rapidly transformed from an outbreak in Wuhan, China, into a widespread global pandemic. A...